Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein

Peptides

Volumn 28, Issue 8, 2007, Pages 1520-1526

  Diez H ^a   Guzman F ^b   Alba, M P ^b   Cuellar A ^a   Thomas, M C ^c   Lopez M C ^c   Rosas, F ^d   Velasco, V ^d   Gonzalez J M ^e   Patarroyo, M E ^b   Puerta, C J ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^d Fundacion Clinica Shaio   (Colombia)

^e UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

Helix; Chagas' disease; Humoral immune response; K1 peptide; KMP 11 protein; Trypanosoma cruzi

Indexed keywords

CYTOTOXIC AGENT; EPITOPE; GLYCOPROTEIN; HLA A ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; KINETOPLASTID MEMBRANE PROTEIN 11; PROTOZOAL PROTEIN; THREONYLLEUCYLGLUTAMYLGLUTAMYLPHENYLALANYLSERYLALANYLLYSYLLEUCINE; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ARTICLE; BLOOD ANALYSIS; CHAGAS DISEASE; CIRCULAR DICHROISM; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL TECHNIQUE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; TRYPANOSOMA CRUZI; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; EPITOPES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 34547857754     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.06.017     Document Type: Article

References (37)

1. Berberich C., Requena J.M., and Alonso C. Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein. Exp Parasitol 85 (1997) 105-108
2. Brekke O.H., Michaelsen T.E., and Sandlie I. The structural requirements for complement activation by IgG: does it hinge on the hinge?. Immunol Today 16 (1995) 85-90
3. Browning M., and Krausa P. Genetic diversity of HLA-A2: evolutionary and functional significance. Immunol Today 17 (1996) 165-170
4. Cifuentes G., Salazar L.M., Vargas L.E., Parra C.A., Vanegas M., Cortes J., et al. Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection. Vaccine 23 (2005) 1579-1587
5. Craig L., Sanschagrin P.C., Rozek A., Lackie S., Kuhn L.A., and Scott J.K. The role of structure in antibody cross-reactivity between peptides and folded proteins. J Mol Biol 281 (1998) 183-201
6. Culshaw S., Larosa K., Tolani H., Han X., Eastcott J.W., Smith D.J., et al. Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding. Infect Immun 75 (2007) 915-923
7. Diez H., Lopez M.C., Thomas M.C., Guzman F., Rosas F., Velasco V., et al. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi. Parasite Immunol 28 (2006) 101-105
8. Diez H., Thomas M.C., Uruena C.P., Santander S.P., Cuervo C.L., Lopez M.C., et al. Molecular characterization of the kinetoplastid membrane protein-11 genes from the parasite Trypanosoma rangeli. Parasitology 130 (2005) 643-651
9. Duranti M.A., Franzoni L., Sartor G., Benedetti A., Iwai L.K., Gruber A., et al. Trypanosoma cruzi: conformational preferences of antigenic peptides bearing the immunodominant epitope of the B13 antigen. Exp Parasitol 93 (1999) 38-44
10. Dyson H.J., and Wright P.E. Antigenic peptides. FASEB J 9 (1995) 37-42
11. Fleischhauer K., Zino E., Arevalo-Herrera M., Herrera S., Valmori D., Cerottini J.C., et al. Differential expression of HLA-A*02 subtypes in Colombian Blacks and Mestizos. Tissue Antigens 51 (1998) 204-209
12. Fonseca S.G., Moins-Teisserenc H., Clave E., Ianni B., Nunes V.L., Mady C., et al. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect 7 (2005) 688-697
13. Garcia F., Sepulveda P., Liegeard P., Gregoire J., Hermann E., Lemonnier F., et al. Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. Microbes Infect 5 (2003) 351-359
14. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82 (1985) 5131-5135
15. Jeener J., Meier B.H., Bachmann P., and Ernst R.R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71 (1979) 4546-4554
16. Jensen A.T., Gasim S., Ismail A., Gaafar A., Kurtzhals J.A., Kemp M., et al. Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11. Scand J Immunol 48 (1998) 103-109
17. Kabsch W., and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 (1983) 2577-2637
18. Laucella S.A., Postan M., Martin D., Hubby Fralish B., Albareda M.C., Alvarez M.G., et al. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189 (2004) 909-918
19. Maranon C., Thomas M.C., Planelles L., and Lopez M.C. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. Mol Immunol 38 (2001) 279-287
20. Martin D.L., Weatherly D.B., Laucella S.A., Cabinian M.A., Crim M.T., Sullivan S., et al. CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2 (2006) e77
21. Michailowsky V., Luhrs K., Rocha M.O., Fouts D., Gazzinelli R.T., and Manning J.E. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect Immun 71 (2003) 3165-3171
22. Miyahira Y., Takashima Y., Kobayashi S., Matsumoto Y., Takeuchi T., Ohyanagi-Hara M., et al. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect Immun 73 (2005) 7356-7365
23. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98 (2003) 577-591
24. Morell M., Thomas M.C., Caballero T., Alonso C., and Lopez M.C. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine 24 (2006) 7046-7055
25. Morgan J., Colley D.G., Pinto Dias J.C., Gontijo E.D., Bahia-Oliveira L., Correa-Oliveira R., et al. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease. J Parasitol 84 (1998) 641-643
26. Morgan J., Dias J.C., Gontijo E.D., Bahia-Oliveira L., Correa-Oliveira R., Colley D.G., et al. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 55 (1996) 355-359
27. Motran C.C., Serra H.M., Gea S.E., Vullo C.M., and Vottero-Cima E. Antibody isotypes profiles against Trypanosoma cruzi acidic antigens in two Amerindian populations from a Chagas' disease endemic area. Acta Trop 58 (1994) 105-114
28. Planelles L., Thomas M.C., Alonso C., and Lopez M.C. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 69 (2001) 6558-6563
29. Ramirez J.R., Berberich C., Jaramillo A., Alonso C., and Velez I.V. Molecular and antigenic characterization of the Leishmania (Viannia) panamensis kinetoplastid membrane protein-11. Mem Inst Oswaldo Cruz 93 (1998) 247-254
30. Rance M., Sorensen O.W., Bodenhausen G., Wagner G., Ernst R.R., and Wuthrich K. Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun 117 (1983) 479-485
31. Richardson J.S., and Richardson D.C. Principles and patterns of protein conformation. In: Fassman G.D. (Ed). Prediction of protein structure and the principles of protein conformation (1985), Plenum Press, New York 1-98
32. Thomas M.C., Garcia-Perez J.L., Alonso C., and Lopez M.C. Molecular characterization of KMP11 from Trypanosoma cruzi: a cytoskeleton-associated protein regulated at the translational level. DNA Cell Biol 19 (2000) 47-57
33. Thomas M.C., Longobardo M.V., Carmelo E., Maranon C., Planelles L., Patarroyo M.E., et al. Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol 123 (2001) 465-471
34. Tolson D.L., Jardim A., Schnur L.F., Stebeck C., Tuckey C., Beecroft R.P., et al. The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation. Infect Immun 62 (1994) 4893-4899
35. Trujillo C., Ramirez R., Velez I.D., and Berberich C. The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Lett 70 (1999) 203-209
36. Wien M.W., Filman D.J., Stura E.A., Guillot S., Delpeyroux F., Crainic R., et al. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope. Nat Struct Biol 2 (1995) 232-243
37. World Health Organization. Control of Chagas' disease. WHO Technical Report Series 2002;905:1-120.